174 related articles for article (PubMed ID: 20054981)
1. The serpin saga; development of a new class of virus derived anti-inflammatory protein immunotherapeutics.
Lucas A; Liu L; Dai E; Bot I; Viswanathan K; Munuswamy-Ramunujam G; Davids JA; Bartee MY; Richardson J; Christov A; Wang H; Macaulay C; Poznansky M; Zhong R; Miller L; Biessen E; Richardson M; Sullivan C; Moyer R; Hatton M; Lomas DA; McFadden G
Adv Exp Med Biol; 2009; 666():132-56. PubMed ID: 20054981
[TBL] [Abstract][Full Text] [Related]
2. Serpins, the vasculature, and viral therapeutics.
Richardson J; Viswanathan K; Lucas A
Front Biosci; 2006 Jan; 11():1042-56. PubMed ID: 16146796
[TBL] [Abstract][Full Text] [Related]
3. Viral SERPINS-A Family of Highly Potent Immune-Modulating Therapeutic Proteins.
Varkoly K; Beladi R; Hamada M; McFadden G; Irving J; Lucas AR
Biomolecules; 2023 Sep; 13(9):. PubMed ID: 37759793
[TBL] [Abstract][Full Text] [Related]
4. Deriving Immune-Modulating Peptides from Viral Serine Protease Inhibitors (Serpins).
Yaron JR; Zhang L; Burgin M; Schutz LN; Awo EA; Keinan S; McFadden G; Ambadapadi S; Guo Q; Chen H; Lucas AR
Methods Mol Biol; 2021; 2225():107-123. PubMed ID: 33108660
[TBL] [Abstract][Full Text] [Related]
5. Viral serpin therapeutics from concept to clinic.
Chen H; Zheng D; Davids J; Bartee MY; Dai E; Liu L; Petrov L; Macaulay C; Thoburn R; Sobel E; Moyer R; McFadden G; Lucas A
Methods Enzymol; 2011; 499():301-29. PubMed ID: 21683260
[TBL] [Abstract][Full Text] [Related]
6. Serpins: Development for Therapeutic Applications.
Lucas A; Yaron JR; Zhang L; Macaulay C; McFadden G
Methods Mol Biol; 2018; 1826():255-265. PubMed ID: 30194606
[TBL] [Abstract][Full Text] [Related]
7. The serpin solution; targeting thrombotic and thrombolytic serine proteases in inflammation.
Chen H; Davids JA; Zheng D; Bryant M; Bot I; van Berckel TJ; Biessen E; Pepine C; Ryman K; Progulski-Fox A; Kesavalu L; Moyer R; McFadden G; Lucas A
Cardiovasc Hematol Disord Drug Targets; 2013 Aug; 13(2):99-110. PubMed ID: 23987998
[TBL] [Abstract][Full Text] [Related]
8. Serpins for diagnosis and therapy in cancer.
Zheng D; Chen H; Davids J; Bryant M; Lucas A
Cardiovasc Hematol Disord Drug Targets; 2013 Aug; 13(2):123-32. PubMed ID: 23988000
[TBL] [Abstract][Full Text] [Related]
9. Viral anti-inflammatory reagents: the potential for treatment of arthritic and vasculitic disorders.
Munuswamy-Ramanujam G; Khan KA; Lucas AR
Endocr Metab Immune Disord Drug Targets; 2006 Dec; 6(4):331-43. PubMed ID: 17214579
[TBL] [Abstract][Full Text] [Related]
10. Viral serine protease inhibitors as anti-atherosclerotic therapy.
Bot I; van Berkel TJ; Biessen EA
Curr Opin Investig Drugs; 2007 Sep; 8(9):729-35. PubMed ID: 17729184
[TBL] [Abstract][Full Text] [Related]
11. Viral cross-class serpin inhibits vascular inflammation and T lymphocyte fratricide; a study in rodent models in vivo and human cell lines in vitro.
Viswanathan K; Bot I; Liu L; Dai E; Turner PC; Togonu-Bickersteth B; Richardson J; Davids JA; Williams JM; Bartee MY; Chen H; van Berkel TJ; Biessen EA; Moyer RW; Lucas AR
PLoS One; 2012; 7(9):e44694. PubMed ID: 23049756
[TBL] [Abstract][Full Text] [Related]
12. A randomized controlled, phase 2 trial of the viral serpin Serp-1 in patients with acute coronary syndromes undergoing percutaneous coronary intervention.
Tardif JC; L'Allier PL; Grégoire J; Ibrahim R; McFadden G; Kostuk W; Knudtson M; Labinaz M; Waksman R; Pepine CJ; Macaulay C; Guertin MC; Lucas A
Circ Cardiovasc Interv; 2010 Dec; 3(6):543-8. PubMed ID: 21062996
[TBL] [Abstract][Full Text] [Related]
13. Myxoma viral serpin, Serp-1, a unique interceptor of coagulation and innate immune pathways.
Viswanathan K; Liu L; Vaziri S; Dai E; Richardson J; Togonu-Bickersteth B; Vatsya P; Christov A; Lucas AR
Thromb Haemost; 2006 Mar; 95(3):499-510. PubMed ID: 16525579
[TBL] [Abstract][Full Text] [Related]
14. Secreted immunomodulatory viral proteins as novel biotherapeutics.
Lucas A; McFadden G
J Immunol; 2004 Oct; 173(8):4765-74. PubMed ID: 15470015
[TBL] [Abstract][Full Text] [Related]
15. Crystal Structure of Cleaved Serp-1, a Myxomavirus-Derived Immune Modulating Serpin: Structural Design of Serpin Reactive Center Loop Peptides with Improved Therapeutic Function.
Mahon BP; Ambadapadi S; Yaron JR; Lomelino CL; Pinard MA; Keinan S; Kurnikov I; Macaulay C; Zhang L; Reeves W; McFadden G; Tibbetts S; McKenna R; Lucas AR
Biochemistry; 2018 Feb; 57(7):1096-1107. PubMed ID: 29227673
[TBL] [Abstract][Full Text] [Related]
16. Virus-derived anti-inflammatory proteins: potential therapeutics for cancer.
Zheng D; Chen H; Bartee MY; Williams J; Davids JA; Huang E; Moreb J; Lucas A
Trends Mol Med; 2012 Jun; 18(6):304-10. PubMed ID: 22554906
[TBL] [Abstract][Full Text] [Related]
17. Identification of myxomaviral serpin reactive site loop sequences that regulate innate immune responses.
Dai E; Viswanathan K; Sun YM; Li X; Liu LY; Togonu-Bickersteth B; Richardson J; Macaulay C; Nash P; Turner P; Nazarian SH; Moyer R; McFadden G; Lucas AR
J Biol Chem; 2006 Mar; 281(12):8041-50. PubMed ID: 16407226
[TBL] [Abstract][Full Text] [Related]
18. Methods for Identifying Virus-Derived Serpins.
Rahman MM
Methods Mol Biol; 2018; 1826():73-86. PubMed ID: 30194594
[TBL] [Abstract][Full Text] [Related]
19. Serp-1, a viral anti-inflammatory serpin, regulates cellular serine proteinase and serpin responses to vascular injury.
Dai E; Guan H; Liu L; Little S; McFadden G; Vaziri S; Cao H; Ivanova IA; Bocksch L; Lucas A
J Biol Chem; 2003 May; 278(20):18563-72. PubMed ID: 12637546
[TBL] [Abstract][Full Text] [Related]
20. Viral anti-inflammatory serpin reduces immuno-coagulopathic pathology in SARS-CoV-2 mouse models of infection.
Zhang L; Li YH; Kibler K; Kraberger S; Varsani A; Turk J; Elmadbouly N; Aliskevich E; Spaccarelli L; Estifanos B; Enow J; Zanetti IR; Saldevar N; Lim E; Schlievert J; Browder K; Wilson A; Juan FA; Pinteric A; Garg A; Monder H; Saju R; Gisriel S; Jacobs B; Karr TL; Florsheim EB; Kumar V; Wallen J; Rahman M; McFadden G; Hogue BG; Lucas AR
EMBO Mol Med; 2023 Sep; 15(9):e17376. PubMed ID: 37534622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
